تحميل...
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers
Esophagogastric cancers (EGCa) are a leading cause of cancer related mortality worldwide. It has been recognized that they represent heterogenous diseases based on histology and anatomy. However, it is also increasingly evident that these are diverse malignancies based on genetic alterations, and th...
محفوظ في:
| الحاوية / القاعدة: | J Gastrointest Oncol |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
AME Publishing Company
2016
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056259/ https://ncbi.nlm.nih.gov/pubmed/27747090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.13 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|